RT Conference Proceedings
T1 Analysis of Immunotherapy in Triple negative breast cancer
A1 Burgos-Molina, Antonio Manuel
A1 Alamilla Presuel, Juan Carlos
A1 González Vidal, Alejandro
A1 Ruiz-Gómez, Miguel José
K1 Inmunoterapia - Congresos
K1 Cancer - Congresos
AB TNBC cancer is complicated, most is about PD-L1 mechanism. Too many kinds of immunotherapy have been developed to treat TNCB. Nowadays, is complicated a fast and 100% accurate treatment for TNBC, because of cancer complications like metastasis. Nevertheless, metastasis is still being researched to prevent it and assure a better immunotherapy. Also, the immunotherapies must be improved too.
PB Aseica
YR 2022
FD 2022
LK https://hdl.handle.net/10630/25716
UL https://hdl.handle.net/10630/25716
LA eng
NO Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 24 ene 2026